Perinatal outcomes in twin late preterm pregnancies: results from an Italian area-based, prospective cohort study.
Dichorionic
Evidence based indication
Late preterm
Medical indication
Monochorionic
P PROM
Perinatal oucomes
Twins
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
16 Jun 2022
16 Jun 2022
Historique:
received:
28
02
2022
accepted:
10
06
2022
entrez:
16
6
2022
pubmed:
17
6
2022
medline:
22
6
2022
Statut:
epublish
Résumé
Multiple gestations represent a considerable proportion of pregnancies delivering in the late preterm (LP) period. Only 30% of LP twins are due to spontaneous preterm labor and 70% are medically indicated; among this literature described that 16-50% of indicated LP twin deliveries are non-evidence based. As non-evidence-based delivery indications account for iatrogenic morbidity that could be prevented, the objective of our observational study is to investigate first neonatal outcomes of LP twin pregnancies according to gestational age at delivery, chorionicity and delivery indication, then non evidence-based delivery indications. Prospective cohort study among twins infants born between 34 + 0 and 36 + 6 weeks, in Emilia Romagna, Italy, during 2013-2015. The primary outcome was a composite of adverse perinatal outcomes. Among 346 LP twins, 84 (23.4%) were monochorionic and 262 (75.7%) were dichorionic; spontaneous preterm labor accounted for 85 (24.6%) deliveries, preterm prelabor rupture of membranes for 66 (19.1%), evidence based indicated deliveries were 117 (33.8%), while non-evidence-based indications were 78 (22.5%). When compared to spontaneous preterm labor or preterm prelabor rupture of membranes, pregnancies delivered due to maternal and/or fetal indications were associated with higher maternal age (p < 0.01), higher gestational age at delivery (p < 0.01), Caucasian race (p 0.04), ART use (p < 0.01), gestational diabetes (p < 0.01), vaginal bleeding (p < 0.01), antenatal corticosteroids (p < 0.01), diagnosis of fetal growth restriction (FGR) (p < 0.01), and monochorionic (p < 0.01). Two hundred twenty-six pregnancies (65.3%) had at least one fetus experiencing one composite of adverse perinatal outcome. Multivariate analysis confirmed that delivery indication did not affect the composite of adverse perinatal outcomes; the only characteristic that affect the outcome after controlling for confounding was gestational age at delivery (p < 0.01). Moreover, there was at least one adverse neonatal outcome for 94% of babies born at 34 weeks, for 73% of those born at 35 weeks and for 46% of those born at 36 weeks (p < 0.01). Our study suggests that the decision to deliver or not twins in LP period should consider gestational age at delivery as the main determinant infants' prognosis. Delivery indications should be accurately considered, to avoid iatrogenic early birth responsible of preventable complications.
Sections du résumé
BACKGROUND
BACKGROUND
Multiple gestations represent a considerable proportion of pregnancies delivering in the late preterm (LP) period. Only 30% of LP twins are due to spontaneous preterm labor and 70% are medically indicated; among this literature described that 16-50% of indicated LP twin deliveries are non-evidence based. As non-evidence-based delivery indications account for iatrogenic morbidity that could be prevented, the objective of our observational study is to investigate first neonatal outcomes of LP twin pregnancies according to gestational age at delivery, chorionicity and delivery indication, then non evidence-based delivery indications.
METHODS
METHODS
Prospective cohort study among twins infants born between 34 + 0 and 36 + 6 weeks, in Emilia Romagna, Italy, during 2013-2015. The primary outcome was a composite of adverse perinatal outcomes.
RESULTS
RESULTS
Among 346 LP twins, 84 (23.4%) were monochorionic and 262 (75.7%) were dichorionic; spontaneous preterm labor accounted for 85 (24.6%) deliveries, preterm prelabor rupture of membranes for 66 (19.1%), evidence based indicated deliveries were 117 (33.8%), while non-evidence-based indications were 78 (22.5%). When compared to spontaneous preterm labor or preterm prelabor rupture of membranes, pregnancies delivered due to maternal and/or fetal indications were associated with higher maternal age (p < 0.01), higher gestational age at delivery (p < 0.01), Caucasian race (p 0.04), ART use (p < 0.01), gestational diabetes (p < 0.01), vaginal bleeding (p < 0.01), antenatal corticosteroids (p < 0.01), diagnosis of fetal growth restriction (FGR) (p < 0.01), and monochorionic (p < 0.01). Two hundred twenty-six pregnancies (65.3%) had at least one fetus experiencing one composite of adverse perinatal outcome. Multivariate analysis confirmed that delivery indication did not affect the composite of adverse perinatal outcomes; the only characteristic that affect the outcome after controlling for confounding was gestational age at delivery (p < 0.01). Moreover, there was at least one adverse neonatal outcome for 94% of babies born at 34 weeks, for 73% of those born at 35 weeks and for 46% of those born at 36 weeks (p < 0.01).
CONCLUSION
CONCLUSIONS
Our study suggests that the decision to deliver or not twins in LP period should consider gestational age at delivery as the main determinant infants' prognosis. Delivery indications should be accurately considered, to avoid iatrogenic early birth responsible of preventable complications.
Identifiants
pubmed: 35710441
doi: 10.1186/s13052-022-01297-4
pii: 10.1186/s13052-022-01297-4
pmc: PMC9204959
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
101Subventions
Organisme : Regione Emilia-Romagna
ID : 417149_2014
Investigateurs
Vittorio Basevi
(V)
Frusca Tiziana
(F)
Giuseppe Battagliarin
(G)
Marinella Lenzi
(M)
Gina Ancora
(G)
Luigi Corvaglia
(L)
Informations de copyright
© 2022. The Author(s).
Références
J Pediatr. 1978 Apr;92(4):529-34
pubmed: 305471
Pediatr Neonatol. 2018 Jun;59(3):231-237
pubmed: 29066072
Am J Obstet Gynecol. 2008 Oct;199(4):367.e1-8
pubmed: 18928976
Obstet Gynecol Surv. 2020 Jul;75(7):419-430
pubmed: 32735684
BMC Pregnancy Childbirth. 2019 Aug 5;19(1):276
pubmed: 31382995
N Engl J Med. 2009 Jan 8;360(2):111-20
pubmed: 19129525
J Matern Fetal Neonatal Med. 2022 Jan 25;:1-10
pubmed: 35078377
J Matern Fetal Neonatal Med. 2016;29(9):1520-4
pubmed: 26103779
Am J Obstet Gynecol. 2020 Nov;223(5):B16-B20
pubmed: 32861686
Lancet. 2019 Mar 2;393(10174):899-909
pubmed: 30773280
Obstet Gynecol. 2014 Jul;124(1):182-192
pubmed: 24945455
Fetal Diagn Ther. 2012;32(3):145-55
pubmed: 23006773
Am J Perinatol. 2010 Aug;27(7):537-42
pubmed: 20175042
Pediatrics. 2011 Jun;127(6):1111-24
pubmed: 21624885
Am J Obstet Gynecol. 2010 Oct;203(4):305-15
pubmed: 20728073
Semin Perinatol. 2011 Oct;35(5):277-85
pubmed: 21962627
Pediatrics. 2017 Mar;139(3):
pubmed: 28148728
BJOG. 2016 Apr;123(5):763-70
pubmed: 25976430
Semin Fetal Neonatal Med. 2012 Jun;17(3):120-5
pubmed: 22264582
Pediatrics. 2009 Jul;124(1):234-40
pubmed: 19564305
Obstet Gynecol. 2014 May;123(5):1118-1132
pubmed: 24785876
Semin Fetal Neonatal Med. 2012 Jun;17(3):143-5
pubmed: 22364678
Am J Obstet Gynecol. 2013 Aug;209(2):89-97
pubmed: 23628263
Pediatrics. 2016 Oct;138(4):
pubmed: 27940890
Obstet Gynecol. 2009 Jul;114(1):192-202
pubmed: 19546798
Eur J Obstet Gynecol Reprod Biol. 2013 Feb;166(2):156-60
pubmed: 23219293
Eur J Obstet Gynecol Reprod Biol. 2016 Jul;202:66-70
pubmed: 27180271
Am J Perinatol. 2014 May;31(5):365-72
pubmed: 24166683
Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:23-28
pubmed: 31212221
Am J Obstet Gynecol. 2012 Apr;206(4):300-8
pubmed: 22464066
PLoS Med. 2012;9(4):e1001208
pubmed: 22545024
Am J Clin Pathol. 2020 Jul 7;154(2):225-235
pubmed: 32338725
Obstet Gynecol. 2011 Aug;118(2 Pt 1):323-333
pubmed: 21775849
Obstet Gynecol. 2019 Jan;133(1):e26-e50
pubmed: 30575676
Clin Pediatr (Phila). 2019 Nov;58(13):1381-1386
pubmed: 31556318
Twin Res Hum Genet. 2016 Jun;19(3):222-33
pubmed: 27068715
Obstet Gynecol. 2016 Oct;128(4):e155-64
pubmed: 27661654
JAMA. 2010 Jul 28;304(4):419-25
pubmed: 20664042
Am J Obstet Gynecol. 2011 Nov;205(5):456.e1-6
pubmed: 22035950
J Matern Fetal Neonatal Med. 2021 Oct 15;:1-9
pubmed: 34652249
Natl Vital Stat Rep. 2002 Dec 18;51(2):1-102
pubmed: 12596439
J Perinat Med. 2016 Oct 1;44(8):903-911
pubmed: 27149198
N Engl J Med. 2016 Apr 7;374(14):1311-20
pubmed: 26842679
Fetal Diagn Ther. 2010;27(3):121-33
pubmed: 20413975
EClinicalMedicine. 2022 Jan 10;44:101270
pubmed: 35059618
BJOG. 2013 Nov;120(12):1508-14
pubmed: 23924309
Twin Res Hum Genet. 2016 Jun;19(3):175-83
pubmed: 27203605